MAPT and Alzheimer disease: All three isoforms of p-tau were significantly higher in AD patients than in cognitively unimpaired individuals and were superior to plasma Aβ biomarkers in this task [165], but p-tau217 was the most sensitive marker to predict conversion of MCI to Alzheimer’s dementia [166].